Manrique-Saide, Pablo
Dean, Natalie E.
Halloran, M. Elizabeth
Longini, Ira M.
Collins, Matthew H.
Waller, Lance A.
Gomez-Dantes, Hector
Lenhart, Audrey
Hladish, Thomas J.
Che-Mendoza, Azael
Kirstein, Oscar D.
Romer, Yamila
Correa-Morales, Fabian
Palacio-Vargas, Jorge
Mendez-Vales, Rosa
PĂ©rez, Pilar Granja
Pavia-Ruz, Norma
Ayora-Talavera, Guadalupe
Vazquez-Prokopec, Gonzalo M. http://orcid.org/0000-0002-0710-270X
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U01AI148069, R01 AI139761)
National Institutes of Health (U54 GM111274, R37 AI0032042)
Innovative Vector Control Consortium (DFID:30041-105)
Article History
Received: 23 July 2020
Accepted: 29 September 2020
First Online: 8 October 2020
Ethics approval and consent to participate
: This trial protocol has been approved by Emory University (IRB00108666) and the Autonomous University of Yucatan (CEI-05-2020) and endorsed by the Secretarias de Salud de Yucatan. Written consent/assent will be obtained from participants and kept in a secure place for record-keeping and trial monitor evaluation.
: The authors declare that they have no competing interests.